Wiser Choices in Osteoporosis Choice II: A Decision Aid for Patients and Clinicians

Completed · Not applicable

Conditions studied: Osteoporosis, Osteopenia, Fragility Fractures

In brief

Emphasis in treating osteoporosis has been on T-scores rather than overall fracture risk. Fracture Risk Assessment Tool (FRAX) supports a risk sensitive approach to osteoporosis treatment by providing an absolute fracture risk. FRAX combined with a decision aid may promote a shared decision making approach with patients, allowing the clinician and patient to weigh potential fracture risk (without treatment), versus risk reduction with medication (including side effects and costs). OSTEOPOROSIS CHOICE II will test the effectiveness of: * FRAX * FRAX + decision aid * Usual care (no decision aid and no FRAX given to clinician)

Key facts

Study ID

NCT00949611

Run by

Mayo Clinic

People needed

79

Starts

2009-05-01

Expected to finish

2011-02-01

Last updated by the study team

2016-02-02

Who can join

Age: 50 and older, up to 90. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Peri and Postmenopausal Caucasian, Black, Hispanic and Asian women, aged 50-90
• Bone mineral density (BMD) T-Score < 1.0
• Have appointment with clinician to discuss test results and treatment options
• Patients with FRAX <20% risk who have taken a bisphosphonate for < 5 years.

You may not qualify if…

• Unable to speak or read English

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States
• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.